PALM has been approved to administer the vaccine, and we are eagerly awaiting news as to when we will receive it. Once we do, we will offer it to PALM members who meet the requirements of each phase of the rollout. For more information on the phases of vaccine rollout, please refer to the State of Missouri planned phases.
Our Chief Medical Officer and PALM Health medical team have put together a list of frequently asked questions about the new COVID-19 vaccine, in order to keep you updated and informed with the latest information.
There’s a lot of information circulating about COVID-19 right now. What do we know for certain? In this live Zoom webinar, our PALM Health physicians will address current statistics on the coronavirus, the spectrum of symptoms, medications and supplements for prevention and treatment, the status of a possible vaccination, and concerns about exposure as children head back to school.
As we move into the middle of summer, we are all witnessing COVID-19 continue to spread throughout the country. I am sure this has raised concerns and questions for you and your loved ones, as it has for so many in our community. I’d like to take this moment to address some frequently asked questions, and hopefully provide you with knowledge that can help you feel informed and empowered.
Cases of the new coronavirus are increasing rapidly. What happens if you test positive for COVID-19? Tune into a live webinar panel discussion on Tuesday with PALM Health physicians, who will discuss what to do if you contract the virus, give recommendations for reducing the severity of your symptoms, and answer questions from the audience.
Amid all the buzz about COVID-19, it’s difficult to separate fact from fiction. Tune into a live webinar panel discussion on Friday with PALM Health physicians, who will address the current state of COVID-19, discuss what we know about the virus from a medical perspective, give recommendations for preventing its spread, and answer live questions from the audience as they come in through social media.